Becton, Dickinson and Company (NYSE:BDX) Q1 2023 Earnings Call dated Feb. 02, 2023. Corporate Participants: Francesca DeMartino -- Senior Vice President and Head of
Becton, Dickinson and Company (BDX) Q1 2023 Earnings Call Transcript
Categories
Health Care
Eli Lilly and Company (LLY) Q4 2022 Earnings Call Transcript
Eli Lilly and Company (NYSE: LLY) Q4 2022 earnings call dated Feb. 02, 2023 Corporate Participants: Joe Fletcher -- Senior Vice President of Investor
Cardinal Health Inc (CAH) Q2 2023 Earnings Call Transcript
Cardinal Health Inc (NYSE: CAH) Q2 2023 earnings call dated Feb. 02, 2023 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Jason Hollar -- Chief
MetLife Inc (MET) Q4 2022 Earnings Call Transcript
MetLife Inc (NYSE: MET) Q4 2022 earnings call dated Feb. 02, 2023 Corporate Participants: John Hall -- Senior Vice President and Head of Investor Relations
Quest Diagnostics Inc (DGX) Q4 2022 Earnings Call Transcript
Quest Diagnostics Inc (NYSE: DGX) Q4 2022 earnings call dated Feb. 02, 2023 Corporate Participants: Shawn Bevec -- Vice President, Investor Relations Jim Davis -- President,
Merck (MRK) Earnings: 4Q22 Key Numbers
Merck (NYSE: MRK) reported fourth quarter 2022 earnings results today. Sales increased 2% year-over-year to $13.8 billion. GAAP net income fell 17%
Eli Lilly and Company (LLY) Earnings: 4Q22 Key Numbers
Eli Lilly and Company (NYSE: LLY) reported fourth quarter 2022 earnings results today. Revenue fell 9% year-over-year to $7.3 billion. Reported net income
DGX Infographic: Highlights of Quest Diagnostics’ Q4 2022 earnings
Quest Diagnostics Incorporated (NYSE: DGX) has announced financial results for the fourth quarter of 2022, reporting a sharp decline in adjusted profit
BMY Earnings: Everything you need to know about Bristol Myers’ Q4 results
Bristol Myers Squibb (NYSE: BMY) on Thursday announced results for the fourth quarter of 2022, reporting lower earnings and revenues. The pharma
Advanced Micro Devices Inc (AMD) Q4 2022 Earnings Call Transcript
Advanced Micro Devices Inc (NASDAQ:AMD) Q4 2022 Earnings Call dated Jan. 31, 2023. Corporate Participants: Ruth Cotter -- Senior Vice President, Worldwide Marketing, Human
Edwards Lifesciences Corporation (EW) Q4 2022 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE:EW) Q4 2022 Earnings Call dated Jan. 31, 2023. Corporate Participants: Mark Wilterding -- Senior Vice President, Investor Relations and Treasurer
Amgen Inc (AMGN) Q4 2022 Earnings Call Transcript
Amgen Inc (NASDAQ:AMGN) Q4 2022 Earnings Call dated Jan. 31, 2023. Corporate Participants: Arvind Sood -- Vice President, Investor Relations Robert A. Bradway -- Chairman
Thermo Fisher Scientific Inc (TMO) Q4 2022 Earnings Call Transcript
Thermo Fisher Scientific Inc (NYSE: TMO) Q4 2022 earnings call dated Feb. 01, 2023 Corporate Participants: Rafael Tejada -- Vice President, Investor Relations Marc N.
McKesson Corporation (MCK) Q3 2023 Earnings Call Transcript
McKesson Corporation (NYSE: MCK) Q3 2023 earnings call dated Feb. 01, 2023 Corporate Participants: Rachel Rodriguez -- Vice President, Investor Relations Brian Tyler -- Chief Executive
Boston Scientific Corp (BSX) Q4 2022 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q4 2022 earnings call dated Feb. 01, 2023 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F. Mahoney -- Chairman
Novartis AG (NVS) Q4 2022 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q4 2022 earnings call dated Feb. 01, 2023 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vas Narasimhan -- Chief
AMGN Infographic: Amgen’s Q4 2022 profit drops on flat revenues
Amgen Inc. (NASDAQ: AMGN) said its revenues remained unchanged in the fourth quarter of 2022 when the biotechnology firm's earnings declined. Unadjusted
HUM Earnings: Highlights of Humana’s Q4 2022 financial results
Humana Inc. (NYSE: HUM) on Wednesday reported fourth-quarter 2022 results. Adjusted profit increased from last year, aided by a 7% growth in
BSX Infographic: Highlights of Boston Scientific’s Q4 2022 earnings report
Medical device maker Boston Scientific Corporation (NYSE: BSX) has announced financial results for the fourth quarter of 2022, reporting a decline in
GlaxoSmithKline plc (GSK) Q4 2022 Earnings Call Transcript
GlaxoSmithKline plc (NYSE: GSK) Q4 2022 earnings call dated Feb. 01, 2023 Corporate Participants: Nick Stone -- Head of Global Investor Relations Dame Emma
Pfizer (PFE) expects COVID franchise to reach low point in 2023 and then rebound in 2024
Shares of Pfizer Inc. (NYSE: PFE) were up on Tuesday despite the company delivering mixed results for the fourth quarter of 2022